{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:52:03Z","timestamp":1788263523255,"version":"build-2803163510"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3116,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1111\/j.1523-5378.2007.00482.x","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T16:15:13Z","timestamp":1171901713000},"page":"132-135","source":"Crossref","is-referenced-by-count":14,"title":["Nifuratel-Containing Initial Anti-<i>Helicobacter\u00a0pylori<\/i>Triple Therapy in Children"],"prefix":"10.1111","volume":"12","author":[{"given":"Alexander A.","family":"Nijevitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery U.","family":"Sataev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa N.","family":"Akhmadeyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Arsamastsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,2,19]]},"reference":[{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB1|cit1","first-page":"501","volume-title":"Pediatric Gastroenterology and Nutrition in Clinical Practice","author":"Chelimsky","year":"2002"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00005176-200011000-00007","article-title":"Medical position statement: the North American Society for Pediatric Gastroenterology and Nutrition. Helicobacter pylori infection in children: recommendations for diagnosis and treatment","volume":"31","author":"Gold","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005176-199010000-00005","article-title":"Helicobacter pylori infection and chronic gastritis: clinical, serological and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate","volume":"11","author":"De Giacomo","year":"1990","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1046\/j.1440-1746.2000.2326.x","article-title":"Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole","volume":"15","author":"Nijevitch","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1155\/2005\/390932","article-title":"Canadian Helicobacter Study Group Consensus Conference: update on the approach to Helicobacter pylori infection in children and adolescents - an evidence-based evaluation","volume":"19","author":"Jones","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1651-2227.1998.tb00915.x","article-title":"Helicobacter pylori infection in children","volume":"87","author":"Vandenplas","year":"1998","journal-title":"Acta Paediatr"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1472-8206.2005.00340.x","article-title":"Eradication of Helicobacter pylori: recent advances in treatment","volume":"19","author":"McLoughlin","year":"2005","journal-title":"Fundament Clin Pharmacol"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1046\/j.1365-2036.1999.00563.x","article-title":"Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori- a randomized, controlled trial","volume":"13","author":"Gschwantler","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1365-2036.2000.00844.x","article-title":"Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori","volume":"14","author":"Gisbert","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/14787210.2.4.599","article-title":"Helicobacter pylori infection: diagnosis and treatment","volume":"2","author":"Nakayama","year":"2004","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1365-2036.1997.00258.x","article-title":"Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxicillin in vitro and in clinical treatment in Japan","volume":"11","author":"Miyaji","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 11","key":"10.1111\/j.1523-5378.2007.00482.x-BIB12|cit12","first-page":"A89","article-title":"Increase in resistance to metronidazole and clarithromycin to Helicobacter pylori strains isolated from children before and after treatment in the time span of 1997-2001","volume":"51","author":"Gosciniak","year":"2002","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1111\/j.1523-5378.2007.00482.x-BIB13|cit13","first-page":"A8","article-title":"Evolution of H. pylori primary resistance to antimicrobial agents in Moscow (Russia) in 1996-98","volume":"47","author":"Koudryavtseva","year":"2000","journal-title":"Gut"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/adc.76.4.352","article-title":"One-week treatment for Helicobacter pylori infection","volume":"76","author":"Walsh","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3476(05)81536-7","article-title":"Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children","volume":"123","author":"Israel","year":"1993","journal-title":"J Pediatr"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.1997.00172.x","article-title":"Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection","volume":"11","author":"Segura","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2036.2003.01822.x","article-title":"Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication","volume":"19","author":"Fakheri","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2036.1999.00492.x","article-title":"Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection","volume":"13","author":"Liu","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2036.2005.02656.x","article-title":"Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone","volume":"22","author":"Nijevitch","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB20|cit20","first-page":"60","article-title":"[The use of macmiror in the scheme of eradication therapy of Helicobacter-associated gastritis in children.]","volume":"5","author":"Krivtsova","year":"2001","journal-title":"Pediatrija"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB21|cit21","first-page":"8","article-title":"Microbiological and pharmaco-toxicological profile of nifuratel and its favourable risk\/benefit ratio for the treatment of vulvo-vaginal infections","volume":"52","author":"Mendling","year":"2002","journal-title":"A Rev Arzneimittelforschung"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00005176-199302000-00004","article-title":"Helicobacter pylori infection in children: potential clues to pathogenesis","volume":"16","author":"Mitchell","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl. 1","key":"10.1111\/j.1523-5378.2007.00482.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1136\/gut.43.2008.S10","article-title":"Management of Helicobacter pylori infection in children","volume":"43","author":"Oderda","year":"1998","journal-title":"Gut"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB24|cit24","first-page":"434","article-title":"Is fibronectin (Fn) a factor for optimal quality of healing of peptic ulcer (PU), associated with Helicobacter pylori?","volume":"8","author":"Nijevitch","year":"2003","journal-title":"Helicobacter"},{"issue":"Suppl. 11","key":"10.1111\/j.1523-5378.2007.00482.x-BIB25|cit25","first-page":"A87","article-title":"Eradication of Helicobacter pylori is useful for symptom resolution in children with gastritis","volume":"51","author":"Oderda","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1083-4389.2004.00242.x","article-title":"Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multi-center trial","volume":"9","author":"Oderda","year":"2004","journal-title":"Helicobacter"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB27|cit27","first-page":"459","article-title":"Clarithromycin resistance in Helicobacter pylori-infected children - the West Virginia experience","volume":"8","author":"Elitsur","year":"2003","journal-title":"Helicobacter"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JCM.39.8.3018-3019.2001","article-title":"Helicobacter pylori in children: acquisition of antimicrobial resistance after an initial course of treatment","volume":"39","author":"Kalach","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB29|cit29","first-page":"455","article-title":"Safety of bismuth therapy in Helicobacter pylori-positive children","volume":"8","author":"Shcherbakov","year":"2003","journal-title":"Helicobacter"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2036.2002.01223.x","article-title":"One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies","volume":"16","author":"Wong","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 11","key":"10.1111\/j.1523-5378.2007.00482.x-BIB31|cit31","first-page":"A77","article-title":"Ranitidine bismuth citrate plus amoxicillin and furazolidone in the eradication of H. pylori in children","volume":"49","author":"Nijevitch","year":"2001","journal-title":"Gut"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/AAC.34.9.1637","article-title":"In vitro selection of resistant Helicobacter pylori","volume":"34","author":"Haas","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1523-5378.2007.00482.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00042737-199601000-00008","article-title":"Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori- positive functional dyspepsia","volume":"8","author":"Sch\u00fctze","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1523-5378.2007.00482.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1523-5378.2007.00482.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T01:19:02Z","timestamp":1707614342000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1523-5378.2007.00482.x"}},"subtitle":["Nifuratel Triple Therapy in Childhood"],"short-title":[],"issued":{"date-parts":[[2007,2,19]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1523-5378.2007.00482.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389"],"issn-type":[{"value":"1083-4389","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2,19]]}}}